150
Participants
Start Date
December 31, 2005
Primary Completion Date
April 30, 2006
Study Completion Date
April 30, 2006
Lornoxicam 8 mg
Lornoxicam 16 mg
Placebo
Jefferson Headache Center, Philadelphia
The Innovative Clinical Research Center, Alexandria
Headache Wellness Center, Greensboro
University Headache Center, Chapel Hill
North Carolina Clinical Research, Raleigh
Premiere Research Institute, West Palm Beach
Meridien Research, St. Petersburg
Alabama Clinical Therapeutics, Birmingham
University of South Alabama Neurology, Mobile
Clinical Research Associates, Inc., Nashville
Michigan Head Pain and Neurological Institute, Ann Arbor
Clinical Research Institute, Plymouth
Diamond Headache Clinic, Chicago
Mercy Health Reserach / Ryan Headache Center, St Louis
Headache Care Center, Springfield
Little Rock Family Practice Clinic, Little Rock
Houston Headache Clinic, Houston
Jean Brown Research, Salt Lake City
California Medical Clinic for Headache, Santa Monica
C. Phillip O'Carroll, MD, Inc., Newport Beach
Swedish Pain Center, Seattle
New England Center for Headache, Stamford
NE Medical Research Associates, Inc., North Dartmouth
Lead Sponsor
POZEN
INDUSTRY